[Treatment of tuberculosis. A care program carried out by a working group in the Swedish Pulmonary Medical Society].
D000553:Ambulatory Care; D000995:Antitubercular Agents / Q000097:blood / Q000627:therapeutic use*; D004347:Drug Interactions; D004977:Ethambutol / Q000009:adverse effects / Q000627:therapeutic use; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D007676:Kidney Failure, Chronic / Q000139:chemically induced; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000009:adverse effects / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000635:transmission
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D012293:Rifampin
Tuberkulosbehandling. Vårdprogram utarbetat av en arbetsgrupp inom Svensk lungmedicinsk förening